Oceania announces Director changes as part of Board refresh

Oceania Healthcare Limited (NZX/ASX: OCA) announced today that it has appointed Ms Sarah Ottrey as an independent non-executive director, effective 5 February 2026. Ms Ottrey is a highly experienced director with extensive marketing and commercial leadership experience locally and internationally, including in roles with Unilever and DB Breweries/Heineken. She currently serves as Chair of Christchurch International Airport and the Whitestone Cheese Company, and serves as a New Zealand Member on the APEC Business Advisory Council. Ms Ottrey is also a director of Skyline Enterprises, Mt Cook Alpine Salmon and member of the NZ China Business Council. Previously she has served on the Boards of EBOS Group, The Public Trust, Blue Sky Meats and as a member of the Inland Revenue Risk Assurance Committee. Oceania Board Chair Elizabeth Coutts said “We are delighted to welcome Sarah to the Board. Her deep governance experience, strong commercial acumen and background in customer-focused industries will be a valuable addition to the Board as we continue to enhance our customer offering.” Oceania also announced today that director, Sally Evans, has indicated her intention to retire at the next Annual Shareholder Meeting. Ms Coutts said “I want to take this opportunity to thank Sally for the significant contribution she has made to the Oceania Board since her appointment in 2018. Since joining, she has governed with resident safety and care at the centre of every decision and notably has led the Sustainability Committee through the development of Oceania’s comprehensive sustainability strategy.” “These upcoming changes in Board composition reflect the commencement of the Board’s planned refresh as part of its ongoing succession strategy” Ms Coutts said. The Board has determined that Ms Ottrey is an Independent Director pursuant to the NZX Listing Rules. Ms Ottrey will hold office until Oceania’s next Annual Shareholder Meeting, at which point she will stand for election by shareholders. ENDS This announcement has been authorised for release by Oceania Healthcare Limited’s Board Chair. For all enquiries, please email investor@oceaniahealthcare.co.nz or phone 0800 333 688